Sarepta asks FDA to approve first gene therapy for Duchenne muscular dystrophy

cafead

Administrator
Staff member
  • cafead   Sep 29, 2022 at 07:42: PM
via Sarepta Therapeutics has asked the Food and Drug Administration to approve its gene therapy for Duchenne muscular dystrophy under accelerated review, the company said Thursday.

article source
 

<